Outbreaks of Mycobacterium tuberculosis MDR strains differentially induce neutrophil respiratory burst involving lipid rafts, p38 MAPK and Syk

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Romero, María M ^a   Basile, Juan I ^a   López, Beatriz ^b   Ritacco, Viviana ^b   Barrera, Lucía ^b   Sasiain, María del C ^a   Alemán, Mercedes ^a  

^a Inmunologia de enfermedades respiratorias IMEX CONTICET ANM   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DECTIN 1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE SYK; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; GANGLIOSIDE GM1; GLUCAN; IL8 PROTEIN, HUMAN; LECTIN; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; TLR2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LIPID RAFT; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; RESPIRATORY BURST; SOUTH AMERICA; SOUTH AND CENTRAL AMERICA; TUBERCULOSIS; BACTERIAL CAPSULE; CELL MEMBRANE; HUMAN; IMMUNOLOGY; METABOLISM; MULTIDRUG RESISTANT TUBERCULOSIS; SECRETION (PROCESS);

APOPTOSIS; BACTERIAL CAPSULES; G(M1) GANGLIOSIDE; GLUCANS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-8; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS, C-TYPE; MEMBRANE MICRODOMAINS; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PROTEIN-TYROSINE KINASES; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84901978739     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-262     Document Type: Article

References (57)

1. WHO Global Tuberculosis Control-Surveillance, Planning, Financing 2010, Geneva, Switzerland: WHO, Contract No: WHO/HTM/TB/2008.393, WHO.
2. Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 2007, 189(7):2583-2589. 10.1128/JB.01670-06, 1855800, 17237171.
3. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431(7004):84-87. 10.1038/nature02837, 15343336.
4. Torrelles JB, Schlesinger LS. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis 2010, 90(2):84-93. 10.1016/j.tube.2010.02.003, 2855779, 20199890.
5. Chapman B, Hanks JH, Wallace JH. An electron microscope study of the disposition and fine structure of Mycobacterium lepraemurium in mouse spleen. J Bacteriol 1959, 77(2):205-211. 290351, 13630872.
6. Daffé M, Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 1998, 39:131-203.
7. Ortalo-Magné MA, Dupont MA, Lemassu A, Andersen AB, Gounon P, Daffé M. Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology 1995, 141:1609-1620. 10.1099/13500872-141-7-1609, 7551029.
8. Lemassu A, Daffé M. Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem J 1994, 297(2):351-357. 1137836, 8297342.
9. Glickman MS, Jacobs WR. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 2001, 104(4):477-485. 10.1016/S0092-8674(01)00236-7, 11239406.
10. Dinadayala P, Lemassu A, Granovski P, Cérantola S, Winter N. Revisiting the structure of the anti-neoplastic glucans of Mycobacterium bovis Bacille Calmette-Guerin. Structural analysis of the extracellular and boiling water extract-derived glucans of the vaccine substrains. J Biol Chem 2004, 279(13):12369-12378. 10.1074/jbc.M308908200, 14715664.
11. Van Crevel R, Ottenhoff THM, van der Meer JWM. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002, 15(2):294-309. 10.1128/CMR.15.2.294-309.2002, 118070, 11932234.
12. Yang C-S, Shin D-M, Lee H-M, Son JW, Lee SJ, Akira S, Gougerot-Pocidalo M-A, El-Benna J, Ichijo H, Jo E-K. ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling. Cell Microbiol 2008, 10(3):741-754. 10.1111/j.1462-5822.2007.01081.x, 18028450.
13. Brown GD, Herre J, Williams DL, Willment JA, Marshall ASJ, Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003, 197(9):1119-1124. 10.1084/jem.20021890, 2193964, 12719478.
14. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005, 24(6):1277-1286. 10.1038/sj.emboj.7600594, 556398, 15729357.
15. Underhill DM, Rossnagle E, Lowell CA, Simmons RM. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 2005, 106(7):2543-2550. 10.1182/blood-2005-03-1239, 1895265, 15956283.
16. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuño L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia De Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, Van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006, 6:23-40. 10.1186/1471-2180-6-23, 1468417, 16519816.
17. Ritacco V, Iglesias M-J, Ferrazoli L, Monteserin J, Dalla Costa ER, Cebollada A, Morcillo N, Robledo J, De Waard JH, Araya P, Aristimuño L, Díaz R, Gavin P, Imperiale B, Simonsen V, Zapata EM, Jiménez MS, Rossetti ML, Martin C, Barrera L, Samper S. Conspicuous multidrug-resistant Mycobacterium tuberculosis cluster strains do not trespass country borders in Latin America and Spain. Infection, genetics and evolution J Mol Epid Evol Genetics Inf Dis 2012, 12(4):711-717.
18. Ritacco V, López B, Ambroggi M, Palmero D, Salvadores B, Gravina E, Mazzeo E, Imaz S, Barrera L, . HIV Infection and Geographically Bound Transmission of Drug-Resistant Tuberculosis, Argentina. Emerg Infect Dis 2012, 18:1802-1810. 10.3201/eid1811.120126, 3559153, 23092584, HIV.
19. Eum S-Y, Kong J-H, Hong M-S, Lee Y-J, Kim J-H, Hwang S-H, Cho S-N, Via LE, Barry CE. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 2010, 137(1):122-128. 10.1378/chest.09-0903, 2803122, 19749004.
20. May ME, Spagnuolo PJ. Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Infect Immun 1987, 55(9):2304-2307. 260697, 3040594.
21. Kasahara K, Sato I, Ogura K, Takeuchi H, Kobayashi K, Adachi M. Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis. J Infect Dis 1998, 178(1):127-137. 10.1086/515585, 9652432.
22. Martineau R, Newton SM, Wilkinson KA, Kampmann B, Hall BM, Nawroly N, Packe GE, Davidson RN, Griffiths CJ, Wilkinson RJ. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 2007, 117(7):1988-1994. 10.1172/JCI31097, 1904316, 17607367.
23. Perskvist N, Long M, Stendahl O, Zheng L. Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. J Immunol 2002, 168(12):6358-6365. 10.4049/jimmunol.168.12.6358, 12055253.
24. Alemán M, García A, Saab MA, De La Barrera SS, Finiasz M, Abbate E, Sasiain MC. Mycobacterium tuberculosis-induced activation accelerates apoptosis in peripheral blood neutrophils from patients with active tuberculosis. Am J Respir cell Molecular Biol 2002, 27(5):583-592.
25. Alemán M, Schierloh P, de la Barrera SS, Musella RM, Saab MA, Baldini M, Abbate E, Sasiain MC. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect Immun 2004, 72(9):5150-5158. 10.1128/IAI.72.9.5150-5158.2004, 517458, 15322009.
26. Yadav M, Schorey JS. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 2006, 108:3168-3175. 10.1182/blood-2006-05-024406, 1895517, 16825490.
27. DeLeo FR. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004, 9(4):399-413.
28. Romero MM, Balboa L, Basile JI, López B, Ritacco V, de la Barrera SS, Sasiain MC, Barrera L, Alemán M. Clinical Isolates of Mycobacterium tuberculosis Differ in Their Ability to Induce Respiratory Burst and Apoptosis in Neutrophils as a Possible Mechanism of Immune Escape. Clin Develop Immunol 2012, 2012:152-546.
29. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Investig 1968, 97:77-89.
30. Giaimis J, Lombard Y, Fonteneau P, Muller CD, Levy R, Makaya-Kumba M, Lazdins J, Poindron P. Both mannose and beta-glucan receptors are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by murine macrophages. J Leukoc Biol 1993, 54(6):564-571.
31. Busetto S, Trevisan E, Patriarca P, Menegazzi R. A single-step, sensitive flow cytofluorometric assay for the simultaneous assessment of membrane-bound and ingested Candida albicans in phagocytosing neutrophils. Cytometry J Int Soc Analytical Cytology 2004, 58(2):201-206.
32. Rooyakkers AWJ, Stokes RW. Absence of complement receptor 3 results in reduced binding and ingestion of Mycobacterium tuberculosis but has no significant effect on the induction of reactive oxygen and nitrogen intermediates or on the survival of the bacteria in resident and interferon-gamma activated macrophages. Microb Pathog 2005, 39(3):57-67. 10.1016/j.micpath.2005.05.001, 16084683.
33. Pike LJ. Lipid rafts: bringing order to chaos. J Lipid Res 2003, 44(4):655-667. 10.1194/jlr.R200021-JLR200, 12562849.
34. Ushio-fukai M. Compartmentalization of Redox Signaling Through NADPH Oxidase-Derived ROS. Antioxid Redox Signal 2009, 11(6):1289-1299. 10.1089/ars.2008.2333, 2842113, 18999986.
35. Lafont F, Abrami L, van der Goot FG. Bacterial subversion of lipid rafts. Cur Opin Microbiol 2004, 7:4-10.
36. Lü H-Z, Zhu A-Y, Chen Y, Tang J, Li B-Q. Formation and aggregation of lipid rafts in γδ T cells following stimulation with Mycobacterium tuberculosis antigens. Tohoku J Exp Med 2011, 223(3):193-198. 10.1620/tjem.223.193, 21372520.
37. Shin D-M, Yang C-S, Yu J-M, Lee J-Y, Kim KH, Shin SJ, Takahara K, Lee SJ, Jo E-K. Mycobacterium abscessus activates the macrophage innate immune response via a physical and functional interaction between TLR2 and dectin-1. Cel Microbiol 2008, 10(8):1608-1621.
38. Cywes C, Godenir NL, Hoppe HC, Scholle RR, Steyn LM, Kirsch RE, Ehlers MR. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect Immun 1996, 64(12):5373-5383. 174532, 8945590.
39. Cywes C, Hoppe HC, Daffé M, Ehlers MR. Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun 1997, 65(10):4258-4266. 175611, 9317035.
40. Riedel DD, Kaufmann SHE. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect Immun 1997, 65(11):2620-2623.
41. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJM. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006, 312:1944-1946. 10.1126/science.1124410, 16809538.
42. Malik NJ, Godfrey-Faussett P. Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect Dis 2005, 5(3):174-183.
43. Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 2004, 10:1117-1121. 10.1038/nm1110, 2652755, 15378056.
44. Luciani F, Sisson SA, Jiang H, Francis AR, Tanaka MM. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2009, 106:14711-14715. 10.1073/pnas.0902437106, 2732896, 19706556.
45. O'Sullivan DM, McHugh TD, Gillespie SH. Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture. J Med Microbiol 2010, 59:1533-1535. 10.1099/jmm.0.019091-0, 20724506.
46. Chackerian A, Alt JM, Perera TV, Dascher CC, Behar SM. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 2002, 70(8):4501-4509. 10.1128/IAI.70.8.4501-4509.2002, 128141, 12117962.
47. Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat Immunol 2003, 4(10):949-955. 10.1038/ni981, 14515128.
48. Lee H-M, Yuk J-M, Shin D-M, Jo E-K. Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells. J Clin Immunol 2009, 29(6):795-805. 10.1007/s10875-009-9319-3, 19633936.
49. Zhang X, Majlessi L, Deriaud E, Leclerc C, Lo-Man R. Coactivation of Syk Kinase and MyD88 Adaptor Protein Pathways by Bacteria Promotes Regulatory Properties of Neutrophils. Immunity 2009, 31:761-771. 10.1016/j.immuni.2009.09.016, 19913447.
50. Naroeni A, Porte F. Role of cholesterol and ganglioside GM1 in entry and sort-term survival of Brucella suis in murine macrophages. Infect Immun 2002, 70:1640-1644. 10.1128/IAI.70.3.1640-1644.2002, 127813, 11854258.
51. Jutras I, Abrami L, Dautry-Varsat A. Entry of the Lymphogranuloma Venereum Strain of Chlamydia trachomatis into Host Cells Involves Cholesterol-Rich Membrane Domains. Infect Immun 2003, 71(1):260-266. 10.1128/IAI.71.1.260-266.2003, 143347, 12496174.
52. Gatfield J, Pieters J. Essential Role for Cholesterol in Entry of Mycobacteria into Macrophages. Science 2000, 288(5471):1647-1651. 10.1126/science.288.5471.1647, 10834844.
53. Manes S, Del Real G, Martinez AC. Pathogens: raft hijackers. Nat Rev Immunol 2003, 3:557-568. 10.1038/nri1129, 12876558.
54. Rothfuchs G, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J Immunol 2007, 179(6):3463-3471. 10.4049/jimmunol.179.6.3463, 17785780.
55. Adams EL, Rice PJ, Graves B, Ensley HE, Yu H, Brown GD, Gordon S, Monteiro MA, Papp-szabo E, Lowman DW, Power TD, Wempe MF, Williams DL. Differential High-Affinity Interaction of Dectin-1 with Natural or Synthetic Glucans Is Dependent upon Primary Structure and Is Influenced by Polymer Chain Length and Side-Chain. J Pharmacol Exp Therapeutics 2008, 325:115-123.
56. Herre AS, Marshall J, Caron E, Edwards AD, Williams DL, Schweighoffer E, Tybulewicz V, Reis C, Gordon S, Brown GD. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Immunobiol 2004, 104(13):4038-4045.
57. Torrelles JB, DesJardin LE, MacNeil J, Kaufman TM, Kutzbach B. Inactivation of Mycobacterium tuberculosis mannosyltransferase pim B reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology 2009, 19(7):743-755. 10.1093/glycob/cwp042, 2688391, 19318518.